Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2000
12/21/2000CA2383008A1 Compounds
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2375920A1 Compounds
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/14/2000WO2000075132A1 Process for preparing a 10,11-methanodibenzosuberane derivative
12/14/2000WO2000075121A2 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000WO2000075115A1 Pernasal preparations
12/14/2000WO2000075114A1 Beta2-adrenoceptor agonists
12/14/2000CA2378735A1 Process for preparing 10,11-methanobenzosuberane derivatives
12/14/2000CA2375702A1 Nasal preparations
12/14/2000CA2375283A1 Process for preparing a 10,11-methanodibenzosuberane derivative
12/13/2000EP1058550A1 Substituted semicarbazides and the use thereof
12/13/2000EP0724583B1 Pyridazino quinoline compounds
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159987 Bicyclolactam compounds, use thereof and intermediates for preparing thereof
12/12/2000US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
12/12/2000US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/12/2000CA2160881C 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073273A1 Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/06/2000EP1057812A1 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275909A In-modulators
12/06/2000CN1275564A Quinoline ketone derivant and antianaphylaction using same as active substance
12/05/2000US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
12/05/2000US6156898 Substituted 1,4-dihydro-4-oxonicotinic carboxamides; GABA brain receptor ligands
12/05/2000US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/05/2000US6156766 Heterocyclic benzamides as drugs
11/2000
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071500A1 Halogen compounds
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/29/2000EP1055427A1 Use of primaquine derivatives for the treatment of malaria
11/29/2000EP1054863A2 2-aminoquinoline derivatives having d4-agonistic activity
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP0702727B1 Dyes designed for high sensitivity detection of double-stranded dna
11/29/2000CN1275081A Aqueous liquid preparations
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders
11/28/2000US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative
11/23/2000WO2000069827A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000WO2000013681A3 4-quinolinemethanol derivatives as purine receptor antagonists (i)
11/23/2000DE19922934A1 New 5,5-dihalo- or 4,5,5-trihalo-4-pentenoic acid derivatives, useful as bactericides, fungicides, insecticides, acaricides and nematocides, especially plant fungicides
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/23/2000CA2373509A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/22/2000EP1053227A1 Ppar-gamma modulators
11/22/2000EP1052984A1 Antibacterial agents
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058708C Quinolone derivative for treatment of urinary incontinence, its prepn. method and application
11/21/2000US6150557 Compounds
11/21/2000US6150522 Antagonists of gonadotropin releasing hormone
11/21/2000US6150377 Farnesyl protein transferase inhibitors; anticarcinogenic,-tumor and -proliferative agents; also psoriasis, benign prostatic hypertrophy or restinosis; infections facilitated by farnesyl protein transferase, e.g., malaria or hepatitus delta
11/21/2000US6150356 Potassium channel inhibitors and method
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068202A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000WO2000068201A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000WO2000068200A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000WO2000068199A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000WO2000068193A1 New process
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000068184A1 Aromatic amides
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000CA2373173A1 Aromatic amides
11/16/2000CA2373079A1 Substituted benzolactam compounds
11/16/2000CA2372663A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000CA2371472A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000CA2371469A1 Quinoline derivatives as inhibitors of mek enzymes
11/16/2000CA2370838A1 Quinoline derivatives as inhibitors of mek enzymes
11/15/2000EP1052254A1 Nitrogenous heterocyclic derivatives and medicine thereof
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/15/2000EP1051405A2 Novel dihydroxyhexanoic acid derivatives
11/15/2000EP1051399A1 Phenylalanine derivatives useful as pharmaceutical agents
11/15/2000EP1051165A2 Mitochondria protecting agents for treating mitochondria associated diseases
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147090 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147089 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147088 Antagonists of gonadotropin releasing hormone
11/14/2000US6147063 Therapeutic substituted guanidines
11/09/2000WO2000066560A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066165A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 277